BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23332698)

  • 1. Structure of β-adrenergic receptors.
    Brueckner F; Piscitelli CL; Tsai CJ; Standfuss J; Deupi X; Schertler GF
    Methods Enzymol; 2013; 520():117-51. PubMed ID: 23332698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
    Roy KK; Saxena AK
    J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the functional domains of the beta-adrenergic receptor.
    Strader CD; Sigal IS; Dixon RA
    Am J Respir Cell Mol Biol; 1989 Aug; 1(2):81-6. PubMed ID: 2559762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR activation: a mutagenic spotlight on crystal structures.
    Hulme EC
    Trends Pharmacol Sci; 2013 Jan; 34(1):67-84. PubMed ID: 23245528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into signaling from the beta2-adrenergic receptor structure.
    Audet M; Bouvier M
    Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into agonist-induced activation of G-protein-coupled receptors.
    Deupi X; Standfuss J
    Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional structures of GPcrs for recognition of various ligand structures].
    Ishiguro M
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1598-604. PubMed ID: 21089594
    [No Abstract]   [Full Text] [Related]  

  • 14. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
    Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of structural distortions in the transmembrane helices of GPCRs.
    Deupi X
    Methods Mol Biol; 2012; 914():219-35. PubMed ID: 22976031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
    Guan XM; Amend A; Strader CD
    Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.